If you're on a GLP-1 and you're also on hormone therapy, here's something almost no one is telling you: your hormones might not be absorbing the way they used to. Same dose. Less getting in. And you'd never know it from how you feel — until the symptoms start creeping back.
A lot of women assume that if they're taking their estradiol or progesterone consistently, their levels are consistent. In most circumstances, that's a reasonable assumption. But GLP-1 receptor agonists introduce a variable that changes the equation — one that isn't showing up in the prescribing information and isn't making its way into most clinical conversations.
This post is for the woman who is doing everything right and still feels like something is off.
Why Women Are Combining GLP-1s and Hormone Therapy
The pairing makes clinical sense for many women navigating perimenopause and menopause. Hormone therapy addresses the root hormonal decline — supporting sleep, mood, bone density, cardiovascular health, and cognitive function. A GLP-1 addresses the metabolic disruption that estrogen decline accelerates — weight gain, insulin resistance, appetite dysregulation.
More and more menopause specialists are using both together, particularly for women in their 40s through early 60s who are dealing with both the symptoms of hormonal transition and significant metabolic weight gain. The combination is increasingly common. This makes the absorption issue increasingly important to understand.
The Mechanism Nobody Mentions
GLP-1 receptor agonists work in part by slowing gastric emptying — how quickly food (and everything else you swallow) moves from your stomach into your small intestine. This is intentional and central to the drug's mechanism: slower emptying keeps you fuller longer.
But anything you swallow — including oral medications — is subject to this same slowed transit. The time your oral hormone spends in the stomach changes. The pH environment shifts. The window for absorption through the intestinal wall is different than it was before. For some medications, this matters very little. For hormones, which depend on precise and predictable absorption, it can matter quite a lot.
You can have perfect hormone levels on paper — but hormones still have to be read by your hypothalamus to do their job. If the control center is inflamed and overwhelmed, the message gets garbled no matter how good your labs look.
The result: women taking oral estradiol or oral progesterone alongside a GLP-1 may be absorbing less than their prescription delivers. Their symptoms return. Their labs may look borderline. And no one connects it to the medication sitting in a slower gut.
The Simple Question to Bring to Your Provider
If you're currently taking oral hormones and a GLP-1 together, the most useful conversation you can have with your prescriber is this: does it make sense to switch to a non-oral route of delivery?
Transdermal, sublingual, and vaginal routes bypass the GI tract entirely. They deliver hormone directly into the bloodstream without any dependence on gastric transit speed. This isn't a fringe workaround — it's simply using the delivery mechanism that doesn't interact with the variable your GLP-1 is introducing.
A few practical notes worth knowing:
• Estradiol is available as a patch, gel, or spray — all of which bypass the gut completely. If you're on oral estradiol tablets, some can be used sublingually (dissolved under the tongue) as an alternative when a provider approves.
• Oral progesterone capsules (like Prometrium) are oil-based. They can be used vaginally, which changes the absorption route without requiring a new prescription in most cases. Ask your provider.
• If you're still cycling and using an oral contraceptive for any reason — hormonal regulation, birth control, or perimenopause management — this same absorption concern applies. Worth raising.
The Layer Underneath All of This
Switching to a non-oral hormone route addresses the mechanical problem of GI absorption. But there's a deeper layer that's worth understanding.
Hormones don't just need to get into your bloodstream. They need to be interpreted correctly by the tissue receiving them — and the most important tissue in that chain is your hypothalamus. It's the structure that reads hormone levels and calibrates the whole endocrine system in response.
When the hypothalamus is inflamed or under-nourished — as it often is during the metabolic and hormonal stress of midlife — it loses sensitivity to hormonal signals. You can have adequate hormone levels and still feel like your hormones aren't working. The signal is present; the receiver is offline.
This is why I keep returning to the hypothalamus as the foundation. Sorting out your delivery route is the right first step. Supporting the control center that actually reads the signal is the step that makes it all work.
For your appointment: Write down when you take your hormone and when you take your GLP-1. If they're within a few hours of each other, that's relevant information for your provider. Ask specifically: "Given how GLP-1s affect gastric emptying, should I be on a transdermal or non-oral form of my hormone therapy?"
The Foundation That Makes Everything Else Work
Whether you're combining these two therapies or not, the principle holds: a hypothalamus that can actually receive and process hormonal signals is the foundation everything else is built on. That's what determines whether your hormone therapy works, whether your appetite regulation returns, whether you sleep through the night, and whether your metabolism does what you ask it to do.
Supporting that control center is where I always start — with my patients, and with the women who find their way here.
→ Get the free Hormone Reboot Training — it's the step-by-step guide to supporting the hypothalamus so your body can actually use what you're giving it.
Continue Reading This Series
• Part 1: Ozempic & Your Brain
• Part 2: GLP-1s & Hormone Therapy (this post)
0 Comments